Inventor · disambiguated record
Jeffrey I. Cohen
Also filed as: COHEN JEFFREY · COHEN JEFFREY I
17 granted patents·3 pending applications·60 citations·filing 1988–2024
90Inventor score
Files withUS HEALTH11THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES3COHEN JEFFREY I2IMMUNEX CORP2GENMAB AS1
Top patents by PatentIndex Score
20 records- 0187US10744199B2Epstein-Barr virus vaccinesTHE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2014·Granted Aug 18, 2020·4 cites·9 claims
- 0282US2024408195A1Epstein-barr virus vaccinesTHE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2024·Application pending·0 cites
- 0380US12410240B2Antibodies and methods for the diagnosis and treatment of Epstein Barr virus infectionUS HEALTH·Filed 2024·Granted Sep 9, 2025·0 cites·16 claims
- 0475US12296004B2Recombinant virus with diminished latency and methods of using sameUS HEALTH·Filed 2022·Granted May 13, 2025·0 cites·13 claims
- 0575US11926656B2Antibodies and methods for the diagnosis and treatment of Epstein Barr Virus infectionUS HEALTH·Filed 2021·Granted Mar 12, 2024·0 cites·20 claims
- 0675US2024390706A1Antibodies and methods for the diagnosis, prevention, and treatment of epstein barr virus infectionUS HEALTH·Filed 2024·Application pending·0 cites
- 0770US12005115B2Epstein-barr virus vaccinesTHE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2020·Granted Jun 11, 2024·0 cites·1 claims
- 0868US11305009B2Recombinant virus with diminished latency and methods of using sameUS HEALTH·Filed 2018·Granted Apr 19, 2022·0 cites·7 claims
- 0967US12084489B2Antibodies and methods for the diagnosis, prevention, and treatment of Epstein Barr virus infectionUS HEALTH·Filed 2019·Granted Sep 10, 2024·0 cites·32 claims
- 1062US4894228AVaccine against hepatitis A virusUS HEALTH·Filed 1988·Granted Jan 16, 1990·29 cites·6 claims
- 1158US10166285B2Recombinant virus with diminished latency and methods of using sameCOHEN JEFFREY I·Filed 2007·Granted Jan 1, 2019·0 cites·23 claims
- 1255US11236151B2Antibodies and methods for the diagnosis and treatment of Epstein Barr virus infectionTHE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES·Filed 2018·Granted Feb 1, 2022·0 cites·16 claims
- 1353US2023348568A1Epstein-barr virus monoclonal antibodies and uses thereofUS HEALTH·Filed 2021·Application pending·0 cites
- 1452US5726286AIsolated epstein-barr virus BZLF2 proteins that bind MHC class II beta chainsIMMUNEX CORP·Filed 1995·Granted Mar 10, 1998·13 cites·2 claims
- 1550US5925734AIsolated Epstein-Barr virus BZLF2 proteins that bind MHC class II βchainsIMMUNEX CORP·Filed 1997·Granted Jul 20, 1999·5 cites·6 claims
- 1640US12415859B2Methods of producing heterodimeric antibodiesGENMAB AS·Filed 2019·Granted Sep 16, 2025·0 cites·36 claims
- 1737US8916175B2Safer attenuated varicella-zoster virus vaccines with missing or diminished latency of infectionCOHEN JEFFREY I·Filed 2005·Granted Dec 23, 2014·0 cites·7 claims
- 1837US5837260AChimeric hepatitis A vaccineUS HEALTH·Filed 1995·Granted Nov 17, 1998·3 cites·6 claims
- 1937US5478746AcDNA encoding attenuated cell culture adapted hepatitis A virus genomeUS HEALTH·Filed 1993·Granted Dec 26, 1995·6 cites·4 claims
- 2028USRE37381EVaccine against hepatitis A virusUS HEALTH·Filed 1995·Granted Sep 18, 2001·0 cites·24 claims
Join the waitlist — get patent alerts
Get an alert when Jeffrey I. Cohen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →